NCT00634400View on ClinicalTrials.gov

Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM Alternative)

PHASE3CompletedINTERVENTIONAL
Enrollment

6,268

Participants

Timeline

Start Date

March 31, 1999

Primary Completion Date

May 31, 2003

Study Completion Date

May 31, 2003

Conditions
Congestive Heart Failure
Interventions
DRUG

Candesartan

DRUG

Placebo

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY